Transcriptomic drug-response gene signatures are informative for the stratification of patients for clinical trials

J Allergy Clin Immunol. 2022 Jan;149(1):55-57. doi: 10.1016/j.jaci.2021.09.021. Epub 2021 Sep 25.
No abstract available

Keywords: Atopic dermatitis; IL-22; T(H)22; asthma subtypes; fezakinumab; transcriptomics.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Pharmaceutical Preparations*
  • Transcriptome

Substances

  • Antibodies, Monoclonal, Humanized
  • Pharmaceutical Preparations